help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nicolas, V.
Right arrow Articles by Farley, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nicolas, V.
Right arrow Articles by Farley, J. R.

Journal of Clinical Endocrinology & Metabolism, Vol 78, 1011-1016, Copyright © 1994 by Endocrine Society

ARTICLES

Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women: implications for bone loss with aging

V Nicolas, A Prewett, P Bettica, S Mohan, RD Finkelman, DJ Baylink and JR Farley
Jerry L. Pettis Veterans Hospital, Loma Linda, California 92374.

We determined the skeletal content of insulin-like growth factor-I (IGF- I) and transforming growth factor-beta (TGF beta) in human bone as a function of age, using 66 samples of femoral cortical bone obtained from 46 men and 20 women between the ages of 20-64 yr. We found a linear decline in the skeletal content of IGF-I (nanograms per mg protein) with donor age (r = -0.43; P < 0.001) in the total population. The skeletal content of TGF beta also decreased with age (i.e. 1/TGF beta vs. age; r = 0.28; P < 0.02) for the total population. We did not observe any difference in the skeletal growth factor content between male and female donors. IGF-I content, when analyzed by decade divisions of age, showed a reduction between the 20- to 29-yr-old and the 50- to 59-yr-old subjects (P < 0.02). The loss rate of IGF-I was 1.56 ng/mg protein.yr, corresponding to a net loss of 60% of skeletal IGF-I between the ages of 20-60 yr. The loss rate of TGF beta was 0.03 ng/mg protein.yr, corresponding to a net loss of 25% of the skeletal TGF beta between the ages of 20-60 yr.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. Laviola, A. Natalicchio, S. Perrini, and F. Giorgino
Abnormalities of IGF-I signaling in the pathogenesis of diseases of the bone, brain, and fetoplacental unit in humans
Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E991 - E999.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Perrini, A. Natalicchio, L. Laviola, A. Cignarelli, M. Melchiorre, F. De Stefano, C. Caccioppoli, A. Leonardini, S. Martemucci, G. Belsanti, et al.
Abnormalities of Insulin-Like Growth Factor-I Signaling and Impaired Cell Proliferation in Osteoblasts from Subjects with Osteoporosis
Endocrinology, March 1, 2008; 149(3): 1302 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
C Ding, F Cicuttini, F Scott, H Cooley, and G Jones
Association between age and knee structural change: a cross sectional MRI based study
Ann Rheum Dis, April 1, 2005; 64(4): 549 - 555.
[Abstract] [Full Text] [PDF]

Home page
 Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
H. Blain, A. Vuillemin, A. Blain, F. Guillemin, N. D. Talance, B. Doucet, and C. Jeandel
Age-Related Femoral Bone Loss in Men: Evidence for Hyperparathyroidism and Insulin-Like Growth Factor-1 Deficiency
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2004; 59(12): 1285 - 1289.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. H. Baek, W. Y. Lee, K. W. Oh, H. S. Kim, J. H. Han, M. I. Kang, B. Y. Cha, K. W. Lee, H. Y. Son, S. K. Kang, et al.
Changes in the Serum Growth Factors and Osteoprotegerin after Bone Marrow Transplantation: Impact on Bone and Mineral Metabolism
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1246 - 1254.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A.A. Ionescu and E. Schoon
Osteoporosis in chronic obstructive pulmonary disease
Eur. Respir. J., November 2, 2003; 22(46_suppl): 64s - 75s.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Gennari, D. Merlotti, G. Martini, S. Gonnelli, B. Franci, S. Campagna, B. Lucani, N. Dal Canto, R. Valenti, C. Gennari, et al.
Longitudinal Association between Sex Hormone Levels, Bone Loss, and Bone Turnover in Elderly Men
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5327 - 5333.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
T. Akune, N. Ogata, K. Hoshi, N. Kubota, Y. Terauchi, K. Tobe, H. Takagi, Y. Azuma, T. Kadowaki, K. Nakamura, et al.
Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts
J. Cell Biol., October 14, 2002; 159(1): 147 - 156.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Sowers, T. Scholl, J. Grewal, X. Chen, and M. Jannausch
IGF-I, Osteocalcin, and Bone Change in Pregnant Normotensive and Pre-Eclamptic Women
J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5898 - 5903.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. J. Rosen and J. P. Bilezikian
Anabolic Therapy for Osteoporosis
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 957 - 964.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
N. Miyakoshi, C. Richman, X. Qin, D. J. Baylink, and S. Mohan
Effects of Recombinant Insulin-Like Growth Factor-Binding Protein-4 on Bone Formation Parameters in Mice
Endocrinology, December 1, 1999; 140(12): 5719 - 5728.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. R. Center, T. V. Nguyen, P. N. Sambrook, and J. A. Eisman
Hormonal and Biochemical Parameters in the Determination of Osteoporosis in Elderly Men
J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3626 - 3635.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Suzawa, Y. Takeuchi, S. Fukumoto, S. Kato, N. Ueno, K. Miyazono, T. Matsumoto, and T. Fujita
Extracellular Matrix-Associated Bone Morphogenetic Proteins Are Essential for Differentiation of Murine Osteoblastic Cells in Vitro
Endocrinology, May 1, 1999; 140(5): 2125 - 2133.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Ueland, J. Bollerslev, T. B. Hansen, E. N. Ebbesen, L. Mosekilde, K. Brixen, A. Flyvbjerg, and O. Djøseland
Increased Cortical Bone Content of Insulin-Like Growth Factors in Acromegalic Patients
J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 123 - 127.
[Abstract] [Full Text]

Home page
 CROBMHome page
V.J. Kingsmill
Post-Extraction Remodeling of the Adult Mandible
Critical Reviews in Oral Biology & Medicine, January 1, 1999; 10(3): 384 - 404.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. A. Langlois, C. J. Rosen, M. Visser, M. T. Hannan, T. Harris, P. W. F. Wilson, and D. P. Kiel
Association Between Insulin-Like Growth Factor I and Bone Mineral Density in Older Women and Men: The Framingham Heart Study
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4257 - 4262.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Seck, B. Scheppach, S. Scharla, I. Diel, W. F. Blum, H. Bismar, G. Schmid, B. Krempien, R. Ziegler, and J. Pfeilschifter
Concentration of Insulin-Like Growth Factor (IGF)-I and -II in Iliac Crest Bone Matrix from Pre- and Postmenopausal Women: Relationship to Age, Menopause, Bone Turnover, Bone Volume, and Circulating IGFs
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2331 - 2337.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
C. Ohlsson, B.-A. Bengtsson, O. G. P. Isaksson, T. T. Andreassen, and M. C. Slootweg
Growth Hormone and Bone
Endocr. Rev., February 1, 1998; 19(1): 55 - 79.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Bianda, Y. Glatz, R. Bouillon, E. R. Froesch, and C. Schmid
Effects of Short-Term Insulin-Like Growth Factor-I (IGF-I) or Growth Hormone (GH) Treatment on Bone Metabolism and on Production of 1,25-Dihydroxycholecalciferol in GH-Deficient Adults
J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 81 - 87.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. G. Johansson, E. F. Eriksen, E. Lindh, B. Langdahl, W. F. Blum, A. Lindahl, O. Ljunggren, and S. Ljunghall
Reduced Serum Levels of the Growth Hormone-Dependent Insulin-Like Growth Factor Binding Protein and a Negative Bone Balance at the Level of Individual Remodeling Units in Idiopathic Osteoporosis in Men
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2795 - 2798.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. A. Toogood, J. E. Adams, P. A. O'Neill, and S. M. Shalet
Elderly Patients with Adult-Onset Growth Hormone Deficiency Are Not Osteopenic
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1462 - 1466.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society